274 related articles for article (PubMed ID: 25060690)
1. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk.
Panagiotou G; Mu L; Na B; Mukamal KJ; Mantzoros CS
Metabolism; 2014 Oct; 63(10):1265-71. PubMed ID: 25060690
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation.
Ochman M; Maruszewski M; Wojarski J; Żegleń S; Karolak W; Stanjek-Cichoracka A; Przybyłowski P; Zembala M; Kukla M
Ann Transplant; 2017 Dec; 22():761-768. PubMed ID: 29277835
[TBL] [Abstract][Full Text] [Related]
3. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
[TBL] [Abstract][Full Text] [Related]
4. Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes.
Niersmann C; Carstensen-Kirberg M; Maalmi H; Holleczek B; Roden M; Brenner H; Herder C; Schöttker B
Diabetologia; 2020 Feb; 63(2):410-418. PubMed ID: 31705160
[TBL] [Abstract][Full Text] [Related]
5. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
Saely CH; Leiherer A; Muendlein A; Vonbank A; Rein P; Geiger K; Malin C; Drexel H
Atherosclerosis; 2016 Jan; 244():38-43. PubMed ID: 26590865
[TBL] [Abstract][Full Text] [Related]
6. Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.
Ciresi A; Pizzolanti G; Leotta M; Guarnotta V; Teresi G; Giordano C
J Endocrinol Invest; 2016 Sep; 39(9):1023-30. PubMed ID: 27126309
[TBL] [Abstract][Full Text] [Related]
7. Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease.
Lapointe M; Poirier P; Martin J; Bastien M; Auclair A; Cianflone K
Cardiovasc Diabetol; 2014 Aug; 13():124. PubMed ID: 25139582
[TBL] [Abstract][Full Text] [Related]
8. Circulating omentin is associated with coronary artery disease in men.
Shibata R; Ouchi N; Kikuchi R; Takahashi R; Takeshita K; Kataoka Y; Ohashi K; Ikeda N; Kihara S; Murohara T
Atherosclerosis; 2011 Dec; 219(2):811-4. PubMed ID: 21925659
[TBL] [Abstract][Full Text] [Related]
9. Association of Circulating Omentin-1 with Osteoporosis in a Chinese Type 2 Diabetic Population.
Yan P; Xu Y; Zhang Z; Zhu J; Miao Y; Gao C; Wan Q
Mediators Inflamm; 2020; 2020():9389720. PubMed ID: 33149724
[TBL] [Abstract][Full Text] [Related]
10. Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study.
Nishimura M; Morioka T; Hayashi M; Kakutani Y; Yamazaki Y; Kurajoh M; Mori K; Fukumoto S; Shioi A; Shoji T; Inaba M; Emoto M
Cardiovasc Diabetol; 2019 Dec; 18(1):167. PubMed ID: 31805941
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study.
Herder C; Ouwens DM; Carstensen M; Kowall B; Huth C; Meisinger C; Rathmann W; Roden M; Thorand B
Eur J Endocrinol; 2015 Apr; 172(4):423-32. PubMed ID: 25733068
[TBL] [Abstract][Full Text] [Related]
12. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes.
Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
Cardiovasc Diabetol; 2011 Nov; 10():103. PubMed ID: 22108456
[TBL] [Abstract][Full Text] [Related]
13. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
14. Serum omentin, resistin and tumour necrosis factor-α levels in Behcet patients with and without ocular involvement.
Türkcü FM; Şahin A; Cingü AK; Kaya S; Yüksel H; Cinar Y; Batmaz İ
Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1565-8. PubMed ID: 25904298
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of omentin-1 and visfatin in senile patients with coronary heart disease and heart failure.
Wang XH; Dou LZ; Gu C; Wang XQ
Asian Pac J Trop Med; 2014 Jan; 7(1):55-62. PubMed ID: 24418084
[TBL] [Abstract][Full Text] [Related]
16. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk.
Hayashi M; Morioka T; Hatamori M; Kakutani Y; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M
Diabetes Res Clin Pract; 2019 Feb; 148():160-168. PubMed ID: 30641171
[TBL] [Abstract][Full Text] [Related]
17. Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area.
Li XP; Zeng S; Wang M; Wu XP; Liao EY
J Endocrinol Invest; 2014 Oct; 37(10):991-1000. PubMed ID: 25097104
[TBL] [Abstract][Full Text] [Related]
18. Modifications of serum levels of omentin-1 and other cardiovascular risk factors following weight loss secondary to a Mediterranean hypocaloric diet.
Antonio de Luis D; Izaola O; Primo D; Aller R
Clin Nutr; 2018 Dec; 37(6 Pt A):2280-2283. PubMed ID: 29198435
[TBL] [Abstract][Full Text] [Related]
19. Circulating omentin-1 might be associated with metabolic health status in different phenotypes of body size.
Alizadeh S; Mirzaei K; Mohammadi C; Keshavarz SA; Maghbooli Z
Arch Endocrinol Metab; 2017 Dec; 61(6):567-574. PubMed ID: 28658347
[TBL] [Abstract][Full Text] [Related]
20. Omentin: linking metabolic syndrome and cardiovascular disease.
Zhou JY; Chan L; Zhou SW
Curr Vasc Pharmacol; 2014 Jan; 12(1):136-43. PubMed ID: 22724476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
